These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 233148)

  • 1. Isolation and characterization of antibodies to Clostridium perfringens epsilon toxin from hyperimmune horse serum.
    Worthington RW; Mülders MS
    Onderstepoort J Vet Res; 1979 Sep; 46(3):121-4. PubMed ID: 233148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of Clostridium perfringens epsilon-toxin gene and its high level expression in E. coli.
    Goswami PP; Rupa P; Prihar NS; Garg LC
    Biochem Biophys Res Commun; 1996 Sep; 226(3):735-40. PubMed ID: 8831683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
    Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
    Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production and evaluation of monoclonal antibodies to Clostridium perfringens type D epsilon toxin.
    Boarer CD; Sojka MG; White VJ; Roeder PL
    J Biol Stand; 1988 Jul; 16(3):207-18. PubMed ID: 2902095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase radioimmunoassays for quantitative antibody determination of bacterial exotoxins. Measurement of Clostridium perfringens type D epsilon antitoxin.
    Bernáth S
    Dev Biol Stand; 1976; 32():77-83. PubMed ID: 187514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of various enzyme-linked immunosorbent assays for the detection of Clostridium perfringens beta anti-toxins.
    Krt B
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):293-7. PubMed ID: 10397314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D.
    Kumar A; Kumar S; Sarma Dagger PV; Sharma Double Dagger AK
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):147-50. PubMed ID: 12186772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of Clostridium perfringens beta2-toxin in the gastrointestinal tract of horses.
    Bacciarini LN; Boerlin P; Straub R; Frey J; Gröne A
    Vet Pathol; 2003 Jul; 40(4):376-81. PubMed ID: 12824509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Clostridium perfringens type D epsilon antitoxin in serum of goats by competitive and indirect ELISA.
    Uzal FA; Nielsen K; Kelly WR
    Vet Microbiol; 1997 Sep; 57(2-3):223-31. PubMed ID: 9355257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characterization of a Cl. Perfringens type D strain, isolated in the field and optimization of epsilon toxin biosynthesis in a cell culture].
    Maaroufi A; Metoui W; Rahmouni S; Ghram A
    Arch Inst Pasteur Tunis; 2000; 77(1-4):67-72. PubMed ID: 14658231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium perfringens vaccines.
    Titball RW
    Vaccine; 2009 Nov; 27 Suppl 4():D44-7. PubMed ID: 19837285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with recombinant alpha toxin partially protects broiler chicks against experimental challenge with Clostridium perfringens.
    Cooper KK; Trinh HT; Songer JG
    Vet Microbiol; 2009 Jan; 133(1-2):92-7. PubMed ID: 18635321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative electrochemiluminescence assay for Clostridium perfringens alpha toxin.
    Merrill GA; Rivera VR; Neal DD; Young C; Poli MA
    Anal Biochem; 2006 Oct; 357(2):181-7. PubMed ID: 16949539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A field study of naturally occurring specific antibodies against Clostridium perfringens alpha toxin in Norwegian broiler flocks.
    Heier BT; Lovland A; Soleim KB; Kaldhusdal M; Jarp J
    Avian Dis; 2001; 45(3):724-32. PubMed ID: 11569751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity purification of antibodies specific for 1,4-dihydropyridine Ca2+ channel blockers.
    Sharp AH; Campbell KP
    Circ Res; 1987 Oct; 61(4 Pt 2):I37-45. PubMed ID: 3308157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation and purification of phospholipase C from Clostridium perfringens and antibodies against it using polymeric biospecific adsorbents].
    Shemanova GF; Postnikova TM; Chupov VV; Valuev LO; Platé NA
    Prikl Biokhim Mikrobiol; 1988; 24(3):305-9. PubMed ID: 2902618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.